{"name":"Silence Therapeutics GmbH","slug":"silence-therapeutics-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Atu027 & gemcitabine in treatment arm 1","genericName":"Atu027 & gemcitabine in treatment arm 1","slug":"atu027-gemcitabine-in-treatment-arm-1","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Atu027 & gemcitabine in treatment arm 1","genericName":"Atu027 & gemcitabine in treatment arm 1","slug":"atu027-gemcitabine-in-treatment-arm-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQV3p0WXY5ZXdmOG1nQ0hYMFQyVWs2SDhvWjZYNm1XOGRBLXNPdzEtWGo5WTJvSVVRVi1icS05U1hQcUhGRGxGQWxxdF9qejJuWm1BYlRJT2dYaEVmTzkyclRQWllNSmVMSEZheW9TREtoQ05vTzUxQkdSSXE2UFFJOXNHSkNIU0RhU0szNVVTX1FIRU4zU1RLeWh6Q2d1LVZqRmIxNlJUZWFvSWplYWlWTjJoTW5DdnFYXy1Zc01QQzNiZmxSWVRjWU1ZQnFieE1sbDFwZG9JVGhOOVhZelpWM0ZMMXluU2VrdDBEVDliV0RyRmhZblVDREpvVkRhWGdhZTROUWZFaVlhM3FOWWJuRDZXemRkd21Tc2RDOEsxR3BHcW1saEItV1ZvUkxDendudDZBZHFwUlNCRzc2NVBCYmdrMzc?oc=5","date":"2025-08-28","type":"trial","source":"GlobeNewswire","summary":"Antisense Oligonucleotide Therapeutics Clinical Trial - GlobeNewswire","headline":"Antisense Oligonucleotide Therapeutics Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPN202TUJ4Nm1xZ3AwUEFZbjh0cGl1NWc5WDJFLW03VHhlZnV0R28wOFR4UC0wNlJnSHV6WVY4aG9mdEtDZ1phbHdKWnUyaEhuTzUteERfdkpJdnA1S1VZVGp3TlpwcXhxeEJZeEttTzYwZlNKTHBtZ0dXVGhtSnZZeUs3bkxhTFpVZ2d0c3d5Mm83eGtlRmZJU3FseW5lYVhoeVBESV8zRW9fb1FPTk1jd1ZUb1dyeGlrTFBuMUhCcFBzTnI2azJadG9fWHlxVS1RX0Roc3NNbnIwS19aVEJXbE5zQUJBUHVwdDhhYlluVGZhcXlRVW1wak5xazJ2bFlNMmFzaV9oVENvOWRsTEJFdVRwc2Z3TURveTlIRkJRQXpLV3JWTldMRnBwZG1EdEJSVGdTVlhUVktvS3drSHFrTGFZUmhpcnpOUXl2cEN5OERFZVpE?oc=5","date":"2025-06-17","type":"trial","source":"GlobeNewswire","summary":"Oligonucleotides Clinical Trial Pipeline Analysis - GlobeNewswire","headline":"Oligonucleotides Clinical Trial Pipeline Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPUHhxaGFRWDg0OGxIcXBWWlZreTFab01VRDhtSF9XVjdiQjZhcG5oYWttTmt2bVBvM3VFNWJzalMyWlc0Wms0a0lzX2l3Mm5YcExCN0hLWkktd1ZPcnF3UFNyUDZURksxeHp6eTRCUjc0V1BXTW9HZERUU09IYmZ0RUFtYTNVWDZkWUFsYVplOWFXbHE3R2xpUk9FN0Y1eXBGYUZkZU5pX2xsUTBOQVpDc21GSTNJS2ZIa3JkU0ktRlI4SUZuU1RTQWFNNlJ2bzA2UnBPQkZRaEhIR3FXN2tpUHIzN0xfSEZ5SUowNmVKZXZ4LVFsZmRj?oc=5","date":"2025-02-26","type":"pipeline","source":"PR Newswire","summary":"The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among Pharma Companies | DelveInsight - PR Newswire","headline":"The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among Pharma Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxORnViXzB3VVFUSjAxaVdiMDNFS2d3b1BJallZZS1LVTBrU3NDampweURKeGVtaE9oS2FPc0M0MXpYdDdRSE8tTHNCZlVFSEk1RTdrU1Qxd3p4eGMxNXlpVWlHUTlrNjV5RkJHdjhWajVnSGxzcm9wV0JkMWtBVXZwQ29qcGZlVVdIcURDdm9MbEFuZ3lENTFua2dRQlUydTZjMnVFS2FXS2I0OUpSU2R0UzBnWmZaVlZza1lnSU5YMm5vU2dBeW81bGN4cW9UY1QtdkNCMWxqMUF5WHZGWVYydDc5RWhHWUFSV0FNZTNPOFgxdw?oc=5","date":"2025-02-20","type":"regulatory","source":"GlobeNewswire","summary":"BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment - GlobeNewswire","headline":"BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQUy03MjRnWE5icmRDcHNoZ2l0TU5XbWltTWNadTZhR1lrR3AxaHRwSnMyTkEtY2VBT3diZ1g4WXdyNUVzTGUwcjFCb3pnMkFjZUVnOFg3RkJRamc4cVYtemxoclJIa1UwcmlxQTdjbS1RRWhXSDlOdHZNalNvSFQtZHhPQnM2TS1PZWlLZEt3cTVuMWdNWHN4VFAwTUI2Tk8tNnF0NTV5VlNJTmpiLXN2TjRBMUloeDBKcGdCaUdLM2xqc0NLSUFqUUlmcTlMUHptZlRyTERVUGxZZ2M0?oc=5","date":"2025-02-10","type":"pipeline","source":"GlobeNewswire","summary":"RNA Based Therapeutic Market Size Expected to Reach USD 40.81 Bn by 2034 - GlobeNewswire","headline":"RNA Based Therapeutic Market Size Expected to Reach USD 40.81 Bn by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxORVFEdVh2b3ZPNnhVVlU0Z0xzdlpnOTZCbi1ZSUFhM2lWMnoya1IySEtiRVB0Tl9UV3ozQ3M5T0pRZ0xjRnpCR1RjYUt4ekd0YW5OT29YcjAxM3FObF9fRmZfMWstc2lLdkNsNi1ZVkQ1aHlMWFZnTThNQmpYcmVQQzhscTZXcFBLRnZuQWxjR0M2WDVfMlBjWnRXcG1zSGlyREZzYzV4VWFOS1NGSEpaOWQ1ck9vRUVQaWhSRFZGQ0YyS1BfMkVPTlhpX3NtS0Frd0tOdEhxTWNOSHlpNUVJVWd2SWNJQzZiTU9VQg?oc=5","date":"2024-10-16","type":"pipeline","source":"GlobeNewswire","summary":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - GlobeNewswire","headline":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE54SWpId3VkZFpLNklmR25qZU5CQ1lRVWhyZWNEOEt6SmRmXzMzdWhYejJrS0owVzlqVE5qZllaTlNmNHJSbHNQQjBhLVVmUGhpcFZmRzV2d2dickc2SVo3a0Y3SXhRNEYyRVlSN3FVOEVGWU50THBwaGVfeGdXQQ?oc=5","date":"2024-05-06","type":"pipeline","source":"Straits Research","summary":"Antisense and RNAi Therapeutics Market Size, Top Share | Industry Report, 2033 - Straits Research","headline":"Antisense and RNAi Therapeutics Market Size, Top Share | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1iaDlOcWI3SG5sQU1vOUdXWlV2N0FMX2tGWG9EZlJscU8zMl9CSGVLaXp6ZzlEanFpQk05TUJqME4wdVBnTW4wT21aeE1oZHNGblNaOGNlbFVxb0xrX3ZNeEk3My1wZXVIMFE?oc=5","date":"2023-07-27","type":"pipeline","source":"Wiley Online Library","summary":"SLN124, a GalNAc conjugated 19‐mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteers - Wiley Online Library","headline":"SLN124, a GalNAc conjugated 19‐mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9DMlN4RjZOd01fLTFxTkwzNk4tTlZiaUViX2Y5VTVDcU1rZjl2TmJQbGxfY25HTWg0b01aSDVKZEF0NnJwaks1QjFrVUFCM3NkNHlaUjA4R1BJM0tzdDBJanJ2anN0eVpDbExRYnZ0aGZhaHRVN0N5OTZUcFA?oc=5","date":"2023-05-05","type":"pipeline","source":"Straits Research","summary":"mRNA Vaccines and Therapeutics Market Trends, Growth, & Share-2033 - Straits Research","headline":"mRNA Vaccines and Therapeutics Market Trends, Growth, & Share-2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBFeTByWldzOEMteU9oWEhuaVlTd0s1ZmlDdnc2elVKTkZiZkJpS3c2UUlCMk0wcDVvUGttR245Q0VxQUhpcjllcGptRnpVWm15czJEcWh3ZVEyay1TelpobXhlR3dCSUk4V0FzLQ?oc=5","date":"2021-05-04","type":"pipeline","source":"Wiley Online Library","summary":"SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemi","headline":"SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVm9IdTVHWGtvaXlRVTAxS1NNeWwxckRHWmJQZG16dWNMc0Z2dkNwOGgzSUxGN0VPaWVqRG5BLVFsUV9jcFU3a21tYnBLb3N5Q0RIckN0MVYza1Jfc1lBck1TVE55eTd1T0wwLWNQX2JjM1htVU9NakRHbHQ4a3ZjOF9LTWI2aFNhelNtQlRVMXpZS28?oc=5","date":"2017-07-06","type":"pipeline","source":"Fierce Biotech","summary":"Silence takes Alnylam to court over RNAi IP dispute - Fierce Biotech","headline":"Silence takes Alnylam to court over RNAi IP dispute","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}